We have previously shown that tumor necrosis factor (TNF)a produced from primary tumor-induced expression of two endogenous Toll-like receptor 4 (TLR4) ligands, S100A8 and serum amyloid A3 (SAA3), in pre-metastatic lungs. However, mechanistic details of the signaling network and relevance to pulmonary physiology are poorly understood. Here, we identify Clara cells as a control tower of the network. Clara cell ablation by naphthalene suppressed pulmonary recruitment of CD11b þ TLR4 þ cells and spontaneous lung metastasis. Clara cells turned out to express TLR4 through which SAA3 was auto-amplified. Reciprocal bone marrow transplantation between wild-type and TLR4 knockout mice demonstrated that pulmonary TLR4 þ Clara cells could be derived from bone marrow. SAA3-induced TNFa expression in both alveolar type II cells and macrophages. Primary co-cultures of alveolar type II cells and Clara cells revealed that the induction of TNFa in alveolar type II cells was dependent on the Clara cell-mediated amplification of SAA3. SAA3 induction by bacterial endotoxin also required both Clara cells and TLR4. Thus, pulmonary metastatic soil may feature deregulation of homeostatic inflammatory responses to constant assaults of microbes with endotoxin.
Introduction
The inflammatory nature of tumor microenvironment is closely related to its progression as represented by production of tumor necrosis factor (TNF)a that was initially identified as a lipopolysaccharide (LPS)-induced growth factor (Balkwill, 2009) . TNFa knockout mice have diminished metastasis . We have previously shown that TNFa is necessary and sufficient to induce an endogenous Toll-like receptor (TLR) 4 agonist S100A8 that establishes the pre-metastatic soil in the lungs (Hiratsuka et al., 2006; Vogl et al., 2007) . Although S100A8 induced another TLR4 agonist serum amyloid A3 (SAA3) in pulmonary macrophages and endothelial cells (Hiratsuka et al., 2008) , it was also shown by other groups that TNFa can induce SAA3 expression in granulosa cells (Son et al., 2004) and nuclear factor-kB binds enhancer factor for SAA3 (Bing et al., 2000) . S100A8 appears to have a homeostatic role in pulmonary defense against microbes because S100A8 promotes leukocyte chemotaxis in lungs (Ryckman et al., 2003) and transendothelial as well as transepithelial migration of leukocytes are impaired by inhibition of S100A8 (Raquil et al., 2008; Vogl et al., 2004) . Another proposed receptor for S100A8 is glycan-linked RAGE (receptor for advanced glycation endproducts) (Turovskaya et al., 2008) . RAGE and TLR4 have been proposed to bind high-mobility group box 1 (HMGB1) that is usually localized in the nucleus but has been reported to be released from cells passively by necrosis during tumor chemotherapy, or actively by lysosomal exocytosis on LPS stimulation in monocytes (Gardella et al., 2002; Yang et al., 2010) . Thus, it is likely that TNFa-triggered crisscross signaling with multi-factorial receptors involved in inflammation has an as yet uncovered role in metastatic microenvironment.
An animal model of bronchial asthma under ovalbumin sensitization has also been shown to promote tumor metastasis in a CD4 þ T-cell-dependent manner (Taranova et al., 2008) . As interleukin-4 secreted from CD4 þ T cell was demonstrated to initiate bi-directional amplification of signaling between tumor-associated macrophages and tumor cells (DeNardo et al., 2009) , the allergic inflammation-promoted metastasis stated above may help re-growth of tumor cells in postmetastatic phase. All those information suggest that inflammation in lungs that are destined to allow metastasis may prepare pre-metastatic soil and continue to facilitate formation of metastatic foci.
Interestingly, some studies of mice deficient in genes in TLR4 signaling revealed their biological significance preferentially in the lungs. TLR4 activates nuclear factor-kB on which concomitant activation of activating transcription factor 3 (ATF3) has been proposed to give a negative feedback (Gilchrist et al., 2006) . TLR4 knockout mice display pulmonary emphysema at high age (Zhang et al., 2006) . ATF3-deficient mice suffer from airway inflammation (Gilchrist et al., 2008) . RAGE is abundantly expressed in lungs and RAGE-deficient mice have impaired leukocyte mobilization to the lungs (van Zoelen et al., 2009) .
Preferential sites for lung metastasis are the areas adjacent to terminal bronchioles that are lined with non-ciliated epithelial Clara cells (Kaplan et al., 2006) . Clara cells are known to have a xenobiotic role in the detoxification of air-borne chemicals and secrete surfactant protein-A and CC10. Presence of both proteins in bronchoalveolar lavage (BAL) can serve as a good marker for lung injury. LPS can stimulate TLR4 expressed in alveolar type II cells (Armstrong et al., 2004) . Both TNFa and LPS have been reported to regulate CC10 expression (Yao et al., 1998; Arsalane et al., 2000) . However, CC10 knockout mice showed upregulation of S100A8 where metastasis was enhanced but could be suppressed by inhibition of RAGE with its soluble form working as a decoy receptor (Saha et al., 2010) . In this paper, we show for the first time the mechanisms of how Clara cells contribute to metastatic microenvironment.
Results

Clara cell-ablation reduced spontaneous metastasis by highly metastatic Lewis lung carcinoma (LLC) cells
It is well known that intraperitoneal naphthalene injection results in depletion of Clara cells from terminal bronchioles. Lungs were isolated and fixed 3 days after the naphthalene treatment. Immunostaining for CC10, a Clara cell marker, showed almost complete elimination of Clara cells (Figure 1a) . A highly metastatic Lewis lung carcinoma cell line (3LL) formed few metastatic colonies in the lungs 7 days after subcutaneous inoculation. Histological examination at 14 days after inoculation revealed 15 colonies on average as it is reported (Devoogdt et al., 2003) (Figures 1b and c) . Most of them were not located on the surface of the lungs. A colony situated close to a terminal bronchiole is shown in Figure 1b . In contrast, Clara cell ablation mice that received naphthalene injection 7 days after 3LL transplantation showed a significantly reduced number of micrometastasis 14 days after 3LL inoculation ( Figures  1b and c) .
Naphthalene-treated murine lung Naphthalene injection also results in lung injury and may induce inflammatory responses that are presumed to promote metastasis. Nevertheless, our data support that naphthalene-caused chemical injury suppressed metastasis. To uncover the mechanism, we first took a careful examination of the lungs chemically injured by naphthalene. The number of S100A8-positive cells was increased in the naphthalene-treated lungs (Table 1; Supplementary Figures S1A and S2). Upregulation of S100A8 was reported in CC10 knockout mice in which pulmonary metastasis were enhanced (Saha et al., 2010) . Naphthalene-treated lungs showed more intense immunostaining for SAA3 (1.7-fold) but not for CD31 than control lungs (Table 1 ; Supplementary Figures S1B and C). Enhanced staining for HMGB1 was also found in the naphthalene-treated lungs (2.0-fold) (Table 1 ; Supplementary Figure S1D ), suggesting that HMGB1 protein was released from dying cells and spread out in the lungs. These data suggest that naphthalene-caused inflammation in the lung. However, no significant difference between control and naphthalene-treated lungs was found in CD11b and F4/80 (Table 1 ; Supplementary Figures S1E and F). CD11b and CC10 double immunostaining revealed that the number of CD11b þ cells around terminal bronchioles was increased in the naphthaleneinjured versus control lungs but the total number of CD11b þ cells was not significantly different from control (Supplementary Figure S3) . Lungs were collected on day 14 after implantation (n ¼ 6). *Po0.05.
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Analyzing BAL fluid allows us to monitor the conditions of epithelial cells in alveoli and conducting airways. Unexpectedly, S100A8 was found in BAL fluid from control but not in naphthalene-treated mouse lungs (Supplementary Figure S4A) , although immunohistochemical analysis indicated that the S100A8 level was elevated by naphthalene. SAA3 was detected in neither control nor naphthalene-treated mouse BAL fluids, suggesting that SAA3 was not secreted into lumen of airways. HMGB1 was observed in naphthalene-treated mouse BAL fluids, which is in agreement with the immunostaining results (Table 1 ; Supplementary Figure S1D ). To assess biological activity of these BAL fluids, we performed migration assay using RAW264.7 cells that express TLR4. Both control and naphthalene-treated BAL fluids were active but with no significant difference between them (Supplementary Figure S4B) .
Tumor-bearing mouse lungs with or without naphthalene treatment were also compared immunohistochemically (Table 1 ; Supplementary Figures S1 and S5 ). Naphthalene treatment increased S100A8-positive cell numbers in the tumor-bearing mouse lungs. HMGB1 immunostaining was also increased in naphthalene-treated mice (1.7-fold) (Table 1; Supplementary Figure S1D) .
To confirm the immunostaining results, S100A8 and SAA3 mRNA expression levels in the lungs were quantified by quantitative PCR (qPCR) analysis (Table 1 ; Supplementary Figures S6A and B) . Naphthalene treatment enhanced expression levels of S100A8 and SAA3. The S100A8 expression level in naphthalenetreated tumor-bearing murine lungs was similar to that in naphthalene-treated control murine lungs but the SAA3 expression level of naphthalene-treated tumorbearing murine lungs was significantly lower than that of naphthalene-treated control lungs. As measured previously, the peak concentration of serum SAA3 protein in tumor-bearing mice was around 150 ng/ml at 8 days after subcutaneous transplantation of tumor cells (Maru, 2010) . Although both SAA3 protein and its mRNA were upregulated in the lungs by naphthalene treatment, the serum SAA3 protein levels remained almost unchanged from the baseline (61-68 ng/ml). However, the upregulation of serum SAA3 protein in tumor-bearing mice was abrogated by naphthalene treatment (Table 1 ; Supplementary Figure S6C ). The serum TNFa levels in tumor-bearing mice have been reported to vary from o10 to 10-50 pg/ml (Zugmaier et al., 1991) . In our model, naphthalene treatment and tumor transplantation individually gave mean values around 10 pg/ml (Table 1 ; Supplementary Figure S6D ). The serum TNFa concentration in naphthalene-treated tumor-bearing mice turned out to show no significant change.
Lung recruitment of CD11b þ cells and metastasis in naphthalene-treated mice
Flow cytometric analyses were executed to count CD11b þ cells in the lungs. Naphthalene failed to increase CD11b þ cell populations in the lungs (Table 1 ; Supplementary Figure S7A ), which is consistent with the immunostaining results (Supplementary Figure S1E) , but tumor-bearing mouse lungs showed a higher ratio than control. Naphthalene treatment for tumor-bearing mouse reduced the CD11b þ cell ratio but it was still higher than control mouse lungs (Table 1 ; Supplementary Figure S7A ). A similar pattern of ratios was observed in CD11b þ TLR4 þ cells but naphthalene treatment reduced their ratio to the same level as control (Table 1 ; Supplementary Figure S7A) .
Further, the short-term metastasis assay with LLC (Hiratsuka et al., 2006) revealed that naphthalene efficiently reduced tumor cell recruitment in the lungs (Table 1 ; Supplementary Figure S7B ). In this assay, the tumor-bearing effect (C/A, see Table 1 ) on the tumor cell recruitment was smaller than the result previously reported (Hiratsuka et al., 2006) . The inhibitory effect by naphthalene in tumor-bearing mouse ((C-D)/ C ¼ 60%) was larger than that in non-tumor-bearing mouse ((A-B)/A ¼ 18%).
Which TLR4 is important, lung or bone marrow? Given that Clara cell ablation cancelled recruitment of CD11b þ TLR4 þ cells in the lungs and tumor metastasis and that tumor burden failed to maintain expression levels of SAA3 but not S100A8 in naphthalene-treated mice (Table 1 ; Supplementary Figure S6 ), it is highly likely that Clara cells are involved in SAA3 regulation. We have reported that SAA3 is found to be produced by S100A8 binding to TLR4 (Hiratsuka et al., 2008) . SAA3 expression in Clara cells was confirmed by double immunostaining using antibodies against SAA3 and CC10 in the lungs of LPS-treated mice Table 1 Comparison of immunofluorescent, flow cytometric, quantitative PCR, western blot, ELISA and short-term metastasis assay data for control and tumor-bearing murine lungs with or without naphthalene treatment
1.0 ± 0.2 2.2 ± 0.3 7.6 ± 1.6 4.4 ± 1.4 CD31 (IF)
1.0 ± 0.1 0.9 ± 0.2 1.4 ± 0.2 0.9 ± 0.1 HMGB1 (IF) 1.0±0.5 2.0±0.5 1.4±0.4 2.4±0.4 CD11b (IF)
1.0 ± 0.3 0.9 ± 0.1 1.7 ± 0.4 1.0 ± 0.2 F4/80 (%) (FC) 5.9 ± 1.6 6.5 ± 1.2 7.6 ± 3.2 6.0 ± 1.7 S100A8 (qPCR) b 1.0±0.1 7.8±0.7 1.9±0.2 9.4±1.0 SAA3 (qPCR)
1.0 ± 0.1 9.2 ± 1.0 1.1 ± 0.1 4.5 ± 0.5 SAA3-serum (western blot)
1.0 0.9 1.6 1.0 TNFa-serum (pg/ml) (ELISA) 1.9±1.9 8.9±0.8 10.0±3.2 14.5±7.
3.2±0.7 2.8±1.0 5.1±1.5 2.8±0.9 Short-term metastasis assay Figures S8E and F) . To elucidate the importance of TLR4 in Clara cells, we performed reciprocal bone marrow transplantation (BMT) between wild-type (WT) and TLR4(À/À) mice, and these mice were utilized in the subsequent metastasis assay (Hiratsuka et al., 2006) . WT/TLR4(À/À)-BMT mouse ( ¼ WT mouse that received TLR4(À/À) bone marrow) lungs had fewer numbers of CD11b þ cells and tumor cells (Figure 3 ). As lung recruitment of CD11b þ cells was impaired in TLR4(À/À) mice as reported previously (Hiratsuka et al., 2008) , it can safely be said that TLR4 in bone marrow cells makes an important contribution to the lung metastasis. However, TLR4(À/À)/WT-BMT mouse lungs did not show any significant difference from WT/WT-BMT control mouse lungs in terms of CD11b þ cell populations and metastasis (Figure 3 ). (c) qPCR analysis of SAA3 expression levels in Clara cells (left) and C22 (right) stimulated with GST, GST-S100A8, GST-SAA3 or LPS (0.1 mg/ml) (Clara cell) or TNFa (10 ng/ml) (C22) for 6 h (three independent experiments).
To see if the WT bone marrow cells migrate to the lungs with pre-existing TLR4(À/À) cells after BMT, the lungs derived from WT/TLR4(À/À)-BMT mice and TLR4(À/À)/WT-BMT mice along with WT and TLR4(À/À) controls were immunostained with TLR4 antibody. The staining patterns of the chimeric mice demonstrated that cells at terminal brochioles were a mixture of WT and TLR4 knockout cells (Supplementary Figure S9 ). As all BMT mice were used for this study at least 2 months after BMT operation, transplanted bone marrow cells had enough time to migrate into the lungs to be mixed with pre-existing Clara cells (Wong et al., 2009) . Thus, the reciprocal BMT failed to reduce the biological importance of Clara cell TLR4 in the lungs.
Clara cells express SAA3 in an autocrine manner
In LPS-treated or tumor-bearing mouse, SAA3 expression was induced in epithelia of the conducting airways of lungs (Figures 2a and b) . Although intraperitoneal injection of LPS is a convenient way to observe a highlevel SAA3 expression in the lungs than tumor implantation (Franklin et al., 2003) , the LPS-stimulated SAA3 induction lasted for a much shorter period of time (several hours). SAA3-induced expression of its own mRNA in both primary cultured Clara cells and C22 by roughly 3-and 50-fold, respectively, and TNFa but not S100A8 was also effective for SAA3 upregulation (Figure 2c ). To eliminate any contaminating submolar amounts of LPS in S100A8 and SAA3 preparation, we performed the experiments in the presence of an endotoxin inhibitor (see Materials and methods section). We also confirmed the results with those chemokines purified from mammalian cells (data not shown, Hiratsuka et al., 2008) . The SAA3-induced upregulation was abrogated in Clara cells isolated from TLR4(À/À) mice (Figure 4a ), indicating that TLR4 is a responsible receptor for SAA3 signaling in Clara cells. Moreover, whereas LPS-administered mouse lungs showed a higher SAA3 expression level than that of control mouse lungs, naphthalene treatment cancelled this upregulation as determined by qPCR (Figure 4b ). Taken together, it is likely that SAA3 could be amplified in an autocrine manner. It should to be noted that the naphthalenedependent induction of SAA3 shown in Table 1 and Supplementary Figure S6B is o10-fold upregulation, and the LPS effect shown in Figure 4b is nearly 100-fold.
Alveolar type II epithelial cells produce TNFa on SAA3 stimulation Interestingly, TNFa expression was induced by glutathione S-transferase (GST)-SAA3 in lung slice cultures ( Figure 5a ). As these cultures were carried out in a short period of time (90 min) compared with other cell cultures (6 h) in this study, upregulation of SAA3 expression level by the GST-S100A8, GST-SAA3 or TNFa stimulation was not statistically significant. For example, 90-min incubation was not sufficient to observe the SAA3 expression induced by TNFa (compare with Figure 2c ). To determine which cell type was responsible for this phenomenon, we utilized MLE15, an immortalized alveolar type II epithelial cell line and C22 derived from Clara cells for qPCR-based expression analyses (Figure 5b ). Upregulation of TNFa expression on GST-SAA3 stimulation was observed in MLE15, but not C22 cells, suggesting that alveolar type II cells were engaged in the induction of TNFa by SAA3. Conversely, TNFa directly activated the SAA3 promoter in MLE15 cells (Figure 5c ). Peritoneal macrophages also exhibited an increase in TNFa on SAA3 treatment with no increase in the expression of SAA3 by itself (Table 2 ; Supplementary Figure S10 ). In contrast, lung primary cultured cells, in which macrophages were depleted, showed drastic induction of both SAA3 and TNFa expression on SAA3 stimulation (Table 2 ; Supplementary Figure S10 ). This preparation contained a mixture of Clara cells, alveolar macrophages, endothelial cells and alveolar epithelial cells, and a vast majority (90%) of cells were alveolar epithelial cells as reported (Dobbs et al., 1978) . The induction both SAA3 and TNFa by SAA3 in primary cultured cells was drastically abrogated by 60 and 94%, Expression of S100A8, SAA3 and TNFa. (a) qPCR analysis of relative S100A8, SAA3 and TNFa expression levels in lung organ cultures. Diced lungs were placed onto cell culture inserts and were cultured for 90 min with GST, GST-S100A8 or GST-SAA3 (three independent experiments). (b) qPCR analysis of relative TNFa expression level in C22 and MLE15 cultured with GST, GST-S100A8 or GST-SAA3 for 6 h (three independent experiments). (c) Mouse SAA3 promoter assay. Control luciferase plasmid (pGL3) or pGL3 combined with mouse SAA3 promoter (pGL3-mSAA3) was transfected along with internal control into MLE15 cell line. The following day, transfected cells were incubated for 6 h in low serum (0.5%) medium with or without 10 ng/ml TNFa (three independent experiments). *Po0.05.
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respectively, when the animals were treated with naphthalene (Table 2 ; Supplementary Figure S10 ). The SAA3 upregulation could be derived from the bi-directional stimulation and expression of SAA3 and TNFa in alveolar type II cells (Figures 5b and c) . However, the TNFa production was heavily dependent on Clara cells. This implies that the auto-amplified SAA3 or other growth factors produced in Clara cells may induce TNFa in cells other than Clara cells. In addition, GST-S100A8 stimulation in primary cultured cells resulted in a small but appreciable upregulation of SAA3 mRNA production as reported (2.5-fold compared with GST) (Table 2 ; Supplementary Figure S10) . Thus, there are cross-talks between SAA3 and TNFa signaling in lung alveoli.
Discussion
TNFa-stimulated activation of the S100A8-SAA3-TLR4 cascade in the metastatic lung could be explained as a deregulation of homeostatic inflammatory system. Although gene knockout of S100A8 resulted in embryonic lethality (Passey et al., 1999) and information on that of SAA3 is currently not available, TLR4-deficient mice displayed an organ-specific disorder, pulmonary emphysema (Zhang et al., 2006) . Inhibition of S100A8 abrogated myeloid cell infiltration into pneumonic lungs that requires transendothelial and transepithelial cell migration to reach the pathogens (Kerkhoff et al., 1999; Ryckman et al., 2003; Vogl et al., 2004; Raquil et al., 2008) . Bacteriocidal reactive oxygen species production is regulated by the interaction of S100A8 and cofactors of Nox2, such as p67 and Rac2 (Kerkhoff et al., 2005) or a direct binding between TLR4 and Nox4 (Park et al., 2004) . TLR4 and another proposed endogenous ligand hyaluronan have been shown to regulate lung injury and repair (Jiang et al., 2005) . The recent knockout study of CC10, a xenobiotic protein produced in Clara cells against air-borne pollutants, showed upregulation of S100A8 (Saha et al., 2010) . Given that airways are subjected to constant assaults by microbes and chemicals, the S100A8-SAA3-TLR4 cascade may contribute to a homeostatic level of inflammation in physiological setting.
Danger signals are initiated by cell death releasing molecules that are usually localized in the cells, exogenous pathogens causing of pneumonia, or by chemicals that destruct pulmonary architectures and programs of innate immune system are executed (Shi et al., 2003) . Tumor cells themselves are a danger to the host because they not only cause hypoxic and nutritional stresses but also destroy surrounding tissues. However, in the pre-metastatic lungs the S100A8 cascade is initiated even in the absence of exogenous and endogenous dangers such as microbes and tumor cells. The true danger is to arrive after it. Thus, we proposed to explain the lung metastatic microenvironment as a deregulation of homeostatic inflammation (Maru, 2009 (Maru, , 2010 .
In this paper, we tried to uncover the cytokinechemokine network that constitutes the homeostatic inflammation in the lungs. A clue came from the finding that while CC10 knockout mice showed increased S100A8 with enhancement of lung metastasis (Saha et al., 2010) , ablation of whole Clara cells by naphthalene resulted in inhibition of spontaneous metastasis by 3LL even in the presence of apparent upregulation of S100A8 and SAA3 in the lungs. Although we could observe no metastatic nodule in the lungs at the time of naphthalene treatment, we cannot exclude the possibility that it could change the post-metastatic microenvironment. The abolishment of CC10 in combination with chemically induced inflammation by naphthalene was expected to lead to the establishment of more extensive metaststic microenvironment. CD11b þ TLR4 þ cells were not increased in the naphthalenetreated lungs in the presence of upregulated S100A8 and SAA3 in the lungs. HMGB1 released from dying cells by naphthalene is one of the proposed TLR4 ligands (Yang et al., 2010) and therefore may stimulate expression of SAA3 in TLR4 þ cells other than Clara cells. However, it is unlikely since we observed upregulation of HMGB1 but downregulation of SAA3 in the lungs of naphthalene-treated tumor-bearing mice. The serum TNFa in naphthalene-treated mice was increased (Table 1 ; Supplementary Figure S6D ). This is consistent with the reports from other groups that HMGB1-stimulated another receptor RAGE, that is, abundantly expressed in lung endothelial cells to produce TNFa (Li et al., 2004 ; van Zoelen et al., 2009). 1.0 ± 0.1 1.0 ± 0.1 11.2 ± 3.1 3.9 ± 2.2 Macrophage-TNFa 1.0 ± 0.8 1.5 ± 0.9 84.0 ± 61.4 Primary cultured cells from control lung-TNFa 1.0 ± 0.3 0.8 ± 0.1 125.0 ± 4.5 1.2 ± 0.4 Primary cultured cells from naphthalene-treated lung-TNFa 1.0±0.1 1.3±0.3 8.1±1.5 4.1±1.5
Abbreviations: GST, glutathione S-transferase; SAA3, serum amyloid A3; TNF, tumor necrosis factor. Peritoneal macrophages (macrophage) and lung primary cultured cells (primary cultured cells) from mice treated with or without naphthalene were stimulated with GST, GST-S100A8, GST-SAA3 or TNFa for 6 h, and relative expression levels of SAA3 (upper set) or TNFa (lower set) were quantified. Values obtained from GST-stimulated cells are set as 1.0. See Supplementary Figure S10 for bar charts.
In tumor-bearing mice, the serum SAA3 level is peaked at 8 days after subcutaneous transplantation of the tumor and gradually declines at 14 days when we usually inject labeled tumor cells through the tail vein on purpose (Maru, 2009) . Therefore, the kinetic behavior might be different in naphthalene treatment. The unexpected results made us hypothesize that Clara cells might be a control tower of the cascade. Clara cells were found to express TLR4 through which SAA3 could auto-amplify its own mRNAs ( Figure 6 ). This mechanism may be required for alveolar type II cells located slightly distal to terminal bronchioles and for macrophages to respond to SAA3 to produce TNFa in the lungs. The finding that Clara cell-specific ablation by naphthalene failed to alter the HMGB1-stimulated expression of TNFa in lung endothelial cells may explain the nonsignificant change of serum TNFa levels in tumor-bearing mice by naphthalene treatment. The difference between S100A8 and SAA3 stimulations to induce SAA3 and TNFa could be explained in several ways. First, the binding affinity with TLR4 is one magnitude different between the two (Hiratsuka et al., 2008) . Second, the major receptor for S100A8 could be RAGE, abundantly expressed in the lungs (Ghavami et al., 2008) . Third, binding mechanisms of how the coreceptor MD-2 is involved in binding to S100A8 and SAA3 that still remain unknown. Crystal structure analysis revealed the physical importance of MD-2 for LPS-induced dimerization of TLR4 (Park et al., 2009 ). Docking simulation of S100A8 and TLR4/MD-2 complex provided a possibility that MD-2 might be involved in the binding but it is still unclear (Maru, 2009) . Fourth, different transcription factors or intracellular signaling molecules might be involved in S100A8 and SAA3 signaling. For example, both lipid A and monophosphoryl lipid A bind the TLR4/MD-2 complex but monophosphoryl lipid A selectively activates only the Toll-like Interleukin 1 Receptor domain-containing adaptor-inducing interferon-b (TRIF)-TRIF-related adaptor molecule (TRAM) but not the nuclear factorkB pathway (Mata-Haro et al., 2007) .
Homeostatic control is pertinent to each organ or tissue. Lung homeostasis appears to require myeloid as well as epithelial precursor cell mobilization from bone marrow via circulation. If primary tumor cells can hijack some of the regulators in the homeostasis, tumor cells may be able to be integrated by mistake into the homeostatic program and recruited to the lungs. We assume that homeostasis of which organ is disturbed by primary tumors might partly determine the organotropism in metastasis.
Materials and methods
Animal study C57BL/6 mice were purchased from Clea Japan Inc. (Tokyo, Japan) and TLR4(À/À) mice were provided by Dr S Akira (Osaka University, Osaka, Japan). Mice were used for experiments at 2-3 months of age. To produce tumor-bearing mice, 3 Â 10 6 LLC cells or highly metastatic LLC cells (3LL) were subcutaneously implanted at the back and the mice were maintained for 2 weeks before they are used for the following analyses. For metastasis assay, LLC cells labeled with fluorescent dye (PKH-26, Sigma-Aldrich, St Louis, MO, USA) were injected via tail vein, and 12 h later lungs were taken out to prepare frozen sections. The labeled LLC cells per 100 fields (1 field ¼ 640 Â 860 mm) of lung sections were counted. The 3LL cell line was maintained by serial subcutaneous transplantation in C57BL/6 mice. To generate BMT mice, recipient mice were intravenously received 1 Â 10 6 bone marrow cells from donor mice shortly after a 9 Gy radiation exposure. The BMT mice were then maintained for additional 2 months. All procedures performed with the mice were approved by the Animal Research Committee of Tokyo Women's Medical University.
Clara cell-ablation
To create Clara cell-ablated mice, naphthalene (200 mg/kg body weight) dissolved in corn oil was injected intraperitoneally (Yatera et al., 2001) . According to our CC10 immunostaining results (Figure 1a ), Clara cells were most ablated 3 days after the naphthalene injection and this effect lasted at least for 7 days. Metastasis assays with LLC tail vein injection were conducted at 3 days after the ablation. Control mice received corn oil alone.
Cell culture RAW264.7 and C22 cell lines were purchased from ATCC and DS Pharma Biomedical (Osaka, Japan), respectively. MLE15 cells were kindly provided from Dr Jeffrey Whitsett, Cincinnati Children's Hospital Medical Center, Cincinnati, TNFa originally produced in primary tumor cells controls S100A8-SAA3-TLR4 signaling in lung endothelial cells and macrophages in a paracrine manner as originally described (Hiratsuka et al., 2008 ) (a). Once SAA3 is secreted in the field, SAA3 amplification occurs in an autocrine manner in Clara cells situated in terminal bronchioles. Amplified SAA3 molecules stimulate alveolar type II epithelial cells (ATII) at alveoli, and macrophages, which further produce TNFa (b). At this moment, SAA3 may also activate cell migration of macrophages. The TNFa thus produced stimulates Clara cells to express SAA3 to maintain SAA3 levels in the pre-metastatic field for a long period to give a ground of organotropism in tumor metastasis (c).
OH, USA. All cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) and 1000 units/ml penicillin G sodium, 100 mg/ml streptomycin sulfate. To isolate lung epithelial cells, mouse lungs were minced and digested with collagenase-dispase solution (Liver Digest Medium, Invitrogen, Carlsbad, CA, USA) for 1 h at 37 1C. After passing through a cell strainer (40 mm mesh), the cells were centrifuged and washed twice with Dulbecco's modified Eagle's medium-10% FBS. The cells were then seeded onto tissue culture dishes and were incubated for 1 h at 37 1C to remove adherent non-epithelial cells. Finally, the lung epithelial cells were disseminated on culture dishes. Murine Clara cells were isolated and cultured as described (Atkinson et al., 2008) . To stimulate cells with GST or GST fusion proteins, the cells were cultured with 50 ng/ml of GST, GST-S100A8 or GST-SAA3 in the presence of an endotoxin inhibitor polymixin B at 10 mg/ml for 6 h. GST, GST-S100A8 and GST-SAA3 recombinant proteins were overexpressed in Escherichia coli with pGEX-4T-2 vectors (GE Healthcare, Piscataway, NJ, USA) and purified by using glutathione Sepharose column (GE Healthcare).
Organ culture
Mouse lungs were minced immediately after dissection, and diced lung tissues (2 mm 3 in size) were placed on a cell culture insert (Corning Life Sciences, Lowell, MA, USA, Cat No. 3422) in 24-well plates and were incubated in humidified atmosphere of 5% CO 2 in air at 37 1C for 90 min. Dulbecco's modified Eagle's medium containing 2% FBS, 10 mg/ml polymixin B, and GST, GST-S100A8 or GST-SAA3 recombinant protein (50 ng/ml) was supplied outside the cell culture insert in each well.
Quantitative-PCR Total RNA was extracted using Trizol reagent (Invitrogen). Complementally DNA was synthesized with Superscript III reverse transcriptase with oligo dT primer (Invitrogen). qPCR analysis was carried out using SYBR Green master mixture (Applied Biosystems, Carlsbad, CA, USA) and ABI 7500 Sequence Detection System (Applied Biosystems). Gene expression levels were calculated from Ct values, and the relationship between the Ct value and a logarithm of copy number of a target gene was confirmed to be on a linear line by using the corresponding isolated DNA and its serial dilutions as standard. Thus, gene expression levels for S100A8, SAA3, TLR4 and TNFa were normalized against that of b-actin in each sample. Following primers were used; b-actin, 
Immunohistochemical analysis
Mouse lungs were fixed in 4% paraformaldehyde for 1 h, followed by gentle shaking in 30% sucrose overnight at 4 1C.
The lungs were then embedded in optimal cutting temperature (OCT) compound (Sakura Finetech, Tokyo, Japan). Serial 10-mm sections were mounted on glass slides and washed in phosphate-buffered saline (PBS) before immunostaining. Antibody against CC10, S100A8 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), CD31, CD11b (BD Biosciences, San Luciferase reporter assay MLE cells were seeded in 24-well tissue culture plates and transfected with a pGL3 reporter plasmid containing -272 bp of the 5 0 flanking sequence of the mouse Saa3 genomic DNA together with a Renila luciferase gene containing plasmid as an internal control (Promega, Madison, WI, USA). At 12 h after transfection, medium was switched to 0.5% FBS-containing Dulbecco's modified Eagle's medium with or without 10 ng/ml TNFa. After 6 h, cells were lysed and luciferase activity was measured by using Dual-Luciferase Reporter Assay System and GLOMAX luminometer (Promega).
Western blot analysis and quantification of proteins
The samples were mixed with sodium dodecyl sulfate sample loading buffer containing b-mercaptoethanol, electrophoresed on a polyacrylamide gel, and electrotransferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad). Membranes were blocked with PBS-0.1% Tween 20 (PBST) with 10% FBS, and were incubated with a primary antibody, followed by PBST washes and incubation with a horseradish peroxidase-conjugated secondary antibody. Protein bands were detected using chemiluminescence reagent and an image analyzer (RAS 4000 mini, GE Healthcare). The serum concentration of SAA3 was determined by western blotting with defined amounts of recombinant proteins as a control (Maru, 2010) . Measurement of serum TNFa was performed using ELISA (BD Biosciences).
Statistical analysis
All data were expressed as mean ± s.d. and analyzed using Student 0 s t-test. P-values o0.05 were considered significant (*). NS, not significant.
